U.S. Government to Purchase Minimum of 100,000 Doses of Etesevimab and Bamlanivimab Neutralizing Antibody Therapy

by NASDAQ Market News February 26, 2021

NASDAQ Market News
Click here to email author

BriaCell Announces Closing of US$25 Million Public Offering

Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany

Ads